ID: ALA5287570

Max Phase: Preclinical

Molecular Formula: C6H14N2O4S

Molecular Weight: 210.25

Associated Items:

Representations

Canonical SMILES:  N[C@@H](CCCCS(N)(=O)=O)C(=O)O

Standard InChI:  InChI=1S/C6H14N2O4S/c7-5(6(9)10)3-1-2-4-13(8,11)12/h5H,1-4,7H2,(H,9,10)(H2,8,11,12)/t5-/m0/s1

Standard InChI Key:  PRONDDAHUBCYBW-YFKPBYRVSA-N

Associated Targets(non-human)

Arginase-1 70 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 210.25Molecular Weight (Monoisotopic): 210.0674AlogP: -1.14#Rotatable Bonds: 6
Polar Surface Area: 123.48Molecular Species: ZWITTERIONHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.74CX Basic pKa: 9.52CX LogP: -3.73CX LogD: -3.73
Aromatic Rings: 0Heavy Atoms: 13QED Weighted: 0.48Np Likeness Score: 0.14

References

1. Xiao YC, Yu JL, Dai QQ, Li G, Li GB..  (2021)  Targeting Metalloenzymes by Boron-Containing Metal-Binding Pharmacophores.,  64  (24.0): [PMID:34875836] [10.1021/acs.jmedchem.1c01691]

Source